Banco Santander S.A. Has $16.81 Million Position in Colgate-Palmolive Company $CL

Banco Santander S.A. decreased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 9.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 210,219 shares of the company’s stock after selling 22,802 shares during the quarter. Banco Santander S.A.’s holdings in Colgate-Palmolive were worth $16,805,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Brighton Jones LLC increased its position in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP grew its position in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the period. Schnieders Capital Management LLC. raised its stake in shares of Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in Colgate-Palmolive by 0.4% in the second quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock valued at $61,662,000 after buying an additional 2,768 shares during the period. Finally, Bessemer Group Inc. boosted its stake in Colgate-Palmolive by 16.0% in the second quarter. Bessemer Group Inc. now owns 19,264 shares of the company’s stock valued at $1,751,000 after acquiring an additional 2,650 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of a number of analyst reports. The Goldman Sachs Group reissued a “buy” rating and issued a $100.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 20th. Deutsche Bank Aktiengesellschaft increased their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Bank of America raised their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Finally, UBS Group lifted their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Stock Performance

Shares of CL opened at $97.50 on Friday. The firm has a market cap of $78.59 billion, a P/E ratio of 37.21, a PEG ratio of 4.36 and a beta of 0.29. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.27 and a current ratio of 0.83. The firm’s 50 day moving average price is $87.08 and its two-hundred day moving average price is $82.63.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 EPS. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John Hazlin sold 20,989 shares of the stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares in the company, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock valued at $17,486,693 over the last ninety days. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.